Global Companion Animal Tumor Screening Service Supply, Demand and Key Producers, 2026-2032
The global Companion Animal Tumor Screening Service market size is expected to reach $ 390 million by 2032, rising at a market growth of 7.1% CAGR during the forecast period (2026-2032).
Companion Animal Tumor Screening Service refers to a cancer risk assessment and early screening service for companion animals such as dogs and cats. It typically uses blood, urine, cytology samples, or other biological specimens to detect tumor-related biomarkers, nucleosome signals, circulating cell-free DNA, genetic mutations, epigenetic features, or abnormal cellular morphology, thereby helping assess potential cancer risk in pets. The service is commonly used in annual wellness checkups for senior pets, screening of high-risk breeds, adjunctive diagnosis for suspicious clinical signs, and post-treatment recurrence monitoring. It does not fully replace imaging, histopathology, or clinical diagnosis, but serves as an important front-end tool for early cancer detection and pet health management.
The market for companion animal tumor screening services is primarily driven by factors such as the aging pet population, the rising incidence of tumors in dogs and cats, increased pet owner spending on healthcare, and a growing awareness of preventive health management. As pets are increasingly viewed as family members, owners are placing greater emphasis on early detection, risk assessment, and timely intervention; consequently, the demand for screening has expanded from post-symptomatic testing to include routine check-ups for senior pets, high-risk breeds, and animals with abnormal lumps or no apparent health issues. Meanwhile, continuous technological advancements—including blood biomarkers, liquid biopsies, urine-based molecular testing, gene sequencing, digital cytology, and AI-driven image analysis—have made tumor screening more convenient and less invasive, enabling application across a wider range of clinical scenarios. While the expansion of service networks by veterinary hospitals and reference laboratories, coupled with increased pet insurance coverage for diagnostic procedures, has improved service accessibility, factors such as testing accuracy, the range of cancer types covered, pricing, result interpretation standards, and the diagnostic confirmation process following positive results continue to influence the pace of market adoption.
This report is a detailed and comprehensive analysis of the world market for Companion Animal Tumor Screening Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Companion Animal Tumor Screening Service that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Companion Animal Tumor Screening Service market
2. What is the demand of the global Companion Animal Tumor Screening Service market?
3. What is the year over year growth of the global Companion Animal Tumor Screening Service market?
4. What is the total value of the global Companion Animal Tumor Screening Service market?
5. Who are the Major Players in the global Companion Animal Tumor Screening Service market?
6. What are the growth factors driving the market demand?
Companion Animal Tumor Screening Service refers to a cancer risk assessment and early screening service for companion animals such as dogs and cats. It typically uses blood, urine, cytology samples, or other biological specimens to detect tumor-related biomarkers, nucleosome signals, circulating cell-free DNA, genetic mutations, epigenetic features, or abnormal cellular morphology, thereby helping assess potential cancer risk in pets. The service is commonly used in annual wellness checkups for senior pets, screening of high-risk breeds, adjunctive diagnosis for suspicious clinical signs, and post-treatment recurrence monitoring. It does not fully replace imaging, histopathology, or clinical diagnosis, but serves as an important front-end tool for early cancer detection and pet health management.
The market for companion animal tumor screening services is primarily driven by factors such as the aging pet population, the rising incidence of tumors in dogs and cats, increased pet owner spending on healthcare, and a growing awareness of preventive health management. As pets are increasingly viewed as family members, owners are placing greater emphasis on early detection, risk assessment, and timely intervention; consequently, the demand for screening has expanded from post-symptomatic testing to include routine check-ups for senior pets, high-risk breeds, and animals with abnormal lumps or no apparent health issues. Meanwhile, continuous technological advancements—including blood biomarkers, liquid biopsies, urine-based molecular testing, gene sequencing, digital cytology, and AI-driven image analysis—have made tumor screening more convenient and less invasive, enabling application across a wider range of clinical scenarios. While the expansion of service networks by veterinary hospitals and reference laboratories, coupled with increased pet insurance coverage for diagnostic procedures, has improved service accessibility, factors such as testing accuracy, the range of cancer types covered, pricing, result interpretation standards, and the diagnostic confirmation process following positive results continue to influence the pace of market adoption.
Report Scope
This report studies the global Companion Animal Tumor Screening Service demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for Companion Animal Tumor Screening Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Companion Animal Tumor Screening Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Companion Animal Tumor Screening Service total market, 2021-2032, (USD Million)
- Global Companion Animal Tumor Screening Service total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: Companion Animal Tumor Screening Service total market, key domestic companies, and share, (USD Million)
- Global Companion Animal Tumor Screening Service revenue by player, revenue and market share 2021-2026, (USD Million)
- Global Companion Animal Tumor Screening Service total market by Type, CAGR, 2021-2032, (USD Million)
- Global Companion Animal Tumor Screening Service total market by Application, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Companion Animal Tumor Screening Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Companion Animal Tumor Screening Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Companion Animal Tumor Screening Service Market, Segmentation by Type:
- Blood-based Screening
- Urine-based Screening
- Others
Global Companion Animal Tumor Screening Service Market, Segmentation by Cancer Coverage:
- Multi-cancer Screening Services
- Single-cancer Screening Services
- Cancer-group Screening Services
Global Companion Animal Tumor Screening Service Market, Segmentation by Animal Type:
- Canine Cancer Screening Services
- Feline Cancer Screening Services
- Others
Global Companion Animal Tumor Screening Service Market, Segmentation by Application:
- Routine Wellness Screening
- Senior and High-Risk Animal Screening
- Others
Companies Profiled:
- IDEXX Laboratories
- Antech Diagnostics
- VolitionRx
- Fujifilm
- Zoetis Diagnostics
- LABOKLIN
- NationWide Laboratories
- Midwest Vet Labs
- VDI Laboratory
- HT Vet
- Oncotect
- PETcision
- Bioguard Corporation
- CanCan Diagnostics
Key Questions Answered
1. How big is the global Companion Animal Tumor Screening Service market?2. What is the demand of the global Companion Animal Tumor Screening Service market?
3. What is the year over year growth of the global Companion Animal Tumor Screening Service market?
4. What is the total value of the global Companion Animal Tumor Screening Service market?
5. Who are the Major Players in the global Companion Animal Tumor Screening Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Companion Animal Tumor Screening Service Introduction
1.2 World Companion Animal Tumor Screening Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Companion Animal Tumor Screening Service Total Market by Region (by Headquarter Location)
1.3.1 World Companion Animal Tumor Screening Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Companion Animal Tumor Screening Service Revenue (2021-2032)
1.3.3 China Based Company Companion Animal Tumor Screening Service Revenue (2021-2032)
1.3.4 Europe Based Company Companion Animal Tumor Screening Service Revenue (2021-2032)
1.3.5 Japan Based Company Companion Animal Tumor Screening Service Revenue (2021-2032)
1.3.6 South Korea Based Company Companion Animal Tumor Screening Service Revenue (2021-2032)
1.3.7 ASEAN Based Company Companion Animal Tumor Screening Service Revenue (2021-2032)
1.3.8 India Based Company Companion Animal Tumor Screening Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Companion Animal Tumor Screening Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Companion Animal Tumor Screening Service Consumption Value (2021-2032)
2.2 World Companion Animal Tumor Screening Service Consumption Value by Region
2.2.1 World Companion Animal Tumor Screening Service Consumption Value by Region (2021-2026)
2.2.2 World Companion Animal Tumor Screening Service Consumption Value Forecast by Region (2027-2032)
2.3 United States Companion Animal Tumor Screening Service Consumption Value (2021-2032)
2.4 China Companion Animal Tumor Screening Service Consumption Value (2021-2032)
2.5 Europe Companion Animal Tumor Screening Service Consumption Value (2021-2032)
2.6 Japan Companion Animal Tumor Screening Service Consumption Value (2021-2032)
2.7 South Korea Companion Animal Tumor Screening Service Consumption Value (2021-2032)
2.8 ASEAN Companion Animal Tumor Screening Service Consumption Value (2021-2032)
2.9 India Companion Animal Tumor Screening Service Consumption Value (2021-2032)
3 WORLD COMPANION ANIMAL TUMOR SCREENING SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Companion Animal Tumor Screening Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Companion Animal Tumor Screening Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Companion Animal Tumor Screening Service in 2025
3.2.3 Global Concentration Ratios (CR8) for Companion Animal Tumor Screening Service in 2025
3.3 Companion Animal Tumor Screening Service Company Evaluation Quadrant
3.4 Companion Animal Tumor Screening Service Market: Overall Company Footprint Analysis
3.4.1 Companion Animal Tumor Screening Service Market: Region Footprint
3.4.2 Companion Animal Tumor Screening Service Market: Company Product Type Footprint
3.4.3 Companion Animal Tumor Screening Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Companion Animal Tumor Screening Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Companion Animal Tumor Screening Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Companion Animal Tumor Screening Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Companion Animal Tumor Screening Service Consumption Value Comparison
4.2.1 United States VS China: Companion Animal Tumor Screening Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Companion Animal Tumor Screening Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Companion Animal Tumor Screening Service Companies and Market Share, 2021-2026
4.3.1 United States Based Companion Animal Tumor Screening Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Companion Animal Tumor Screening Service Revenue, (2021-2026)
4.4 China Based Companies Companion Animal Tumor Screening Service Revenue and Market Share, 2021-2026
4.4.1 China Based Companion Animal Tumor Screening Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Companion Animal Tumor Screening Service Revenue, (2021-2026)
4.5 Rest of World Based Companion Animal Tumor Screening Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Companion Animal Tumor Screening Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Companion Animal Tumor Screening Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Companion Animal Tumor Screening Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Blood-based Screening
5.2.2 Urine-based Screening
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Companion Animal Tumor Screening Service Market Size by Type (2021-2026)
5.3.2 World Companion Animal Tumor Screening Service Market Size by Type (2027-2032)
5.3.3 World Companion Animal Tumor Screening Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CANCER COVERAGE
6.1 World Companion Animal Tumor Screening Service Market Size Overview by Cancer Coverage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Cancer Coverage
6.2.1 Multi-cancer Screening Services
6.2.2 Single-cancer Screening Services
6.2.3 Cancer-group Screening Services
6.3 Market Segment by Cancer Coverage
6.3.1 World Companion Animal Tumor Screening Service Market Size by Cancer Coverage (2021-2026)
6.3.2 World Companion Animal Tumor Screening Service Market Size by Cancer Coverage (2027-2032)
6.3.3 World Companion Animal Tumor Screening Service Market Size Market Share by Cancer Coverage (2027-2032)
7 MARKET ANALYSIS BY ANIMAL TYPE
7.1 World Companion Animal Tumor Screening Service Market Size Overview by Animal Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Animal Type
7.2.1 Canine Cancer Screening Services
7.2.2 Feline Cancer Screening Services
7.2.3 Others
7.3 Market Segment by Animal Type
7.3.1 World Companion Animal Tumor Screening Service Market Size by Animal Type (2021-2026)
7.3.2 World Companion Animal Tumor Screening Service Market Size by Animal Type (2027-2032)
7.3.3 World Companion Animal Tumor Screening Service Market Size Market Share by Animal Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Companion Animal Tumor Screening Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Routine Wellness Screening
8.2.2 Senior and High-Risk Animal Screening
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Companion Animal Tumor Screening Service Market Size by Application (2021-2026)
8.3.2 World Companion Animal Tumor Screening Service Market Size by Application (2027-2032)
8.3.3 World Companion Animal Tumor Screening Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 IDEXX Laboratories
9.1.1 IDEXX Laboratories Details
9.1.2 IDEXX Laboratories Major Business
9.1.3 IDEXX Laboratories Companion Animal Tumor Screening Service Product and Services
9.1.4 IDEXX Laboratories Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 IDEXX Laboratories Recent Developments/Updates
9.1.6 IDEXX Laboratories Competitive Strengths & Weaknesses
9.2 Antech Diagnostics
9.2.1 Antech Diagnostics Details
9.2.2 Antech Diagnostics Major Business
9.2.3 Antech Diagnostics Companion Animal Tumor Screening Service Product and Services
9.2.4 Antech Diagnostics Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Antech Diagnostics Recent Developments/Updates
9.2.6 Antech Diagnostics Competitive Strengths & Weaknesses
9.3 VolitionRx
9.3.1 VolitionRx Details
9.3.2 VolitionRx Major Business
9.3.3 VolitionRx Companion Animal Tumor Screening Service Product and Services
9.3.4 VolitionRx Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 VolitionRx Recent Developments/Updates
9.3.6 VolitionRx Competitive Strengths & Weaknesses
9.4 Fujifilm
9.4.1 Fujifilm Details
9.4.2 Fujifilm Major Business
9.4.3 Fujifilm Companion Animal Tumor Screening Service Product and Services
9.4.4 Fujifilm Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Fujifilm Recent Developments/Updates
9.4.6 Fujifilm Competitive Strengths & Weaknesses
9.5 Zoetis Diagnostics
9.5.1 Zoetis Diagnostics Details
9.5.2 Zoetis Diagnostics Major Business
9.5.3 Zoetis Diagnostics Companion Animal Tumor Screening Service Product and Services
9.5.4 Zoetis Diagnostics Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Zoetis Diagnostics Recent Developments/Updates
9.5.6 Zoetis Diagnostics Competitive Strengths & Weaknesses
9.6 LABOKLIN
9.6.1 LABOKLIN Details
9.6.2 LABOKLIN Major Business
9.6.3 LABOKLIN Companion Animal Tumor Screening Service Product and Services
9.6.4 LABOKLIN Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 LABOKLIN Recent Developments/Updates
9.6.6 LABOKLIN Competitive Strengths & Weaknesses
9.7 NationWide Laboratories
9.7.1 NationWide Laboratories Details
9.7.2 NationWide Laboratories Major Business
9.7.3 NationWide Laboratories Companion Animal Tumor Screening Service Product and Services
9.7.4 NationWide Laboratories Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 NationWide Laboratories Recent Developments/Updates
9.7.6 NationWide Laboratories Competitive Strengths & Weaknesses
9.8 Midwest Vet Labs
9.8.1 Midwest Vet Labs Details
9.8.2 Midwest Vet Labs Major Business
9.8.3 Midwest Vet Labs Companion Animal Tumor Screening Service Product and Services
9.8.4 Midwest Vet Labs Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Midwest Vet Labs Recent Developments/Updates
9.8.6 Midwest Vet Labs Competitive Strengths & Weaknesses
9.9 VDI Laboratory
9.9.1 VDI Laboratory Details
9.9.2 VDI Laboratory Major Business
9.9.3 VDI Laboratory Companion Animal Tumor Screening Service Product and Services
9.9.4 VDI Laboratory Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 VDI Laboratory Recent Developments/Updates
9.9.6 VDI Laboratory Competitive Strengths & Weaknesses
9.10 HT Vet
9.10.1 HT Vet Details
9.10.2 HT Vet Major Business
9.10.3 HT Vet Companion Animal Tumor Screening Service Product and Services
9.10.4 HT Vet Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 HT Vet Recent Developments/Updates
9.10.6 HT Vet Competitive Strengths & Weaknesses
9.11 Oncotect
9.11.1 Oncotect Details
9.11.2 Oncotect Major Business
9.11.3 Oncotect Companion Animal Tumor Screening Service Product and Services
9.11.4 Oncotect Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Oncotect Recent Developments/Updates
9.11.6 Oncotect Competitive Strengths & Weaknesses
9.12 PETcision
9.12.1 PETcision Details
9.12.2 PETcision Major Business
9.12.3 PETcision Companion Animal Tumor Screening Service Product and Services
9.12.4 PETcision Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 PETcision Recent Developments/Updates
9.12.6 PETcision Competitive Strengths & Weaknesses
9.13 Bioguard Corporation
9.13.1 Bioguard Corporation Details
9.13.2 Bioguard Corporation Major Business
9.13.3 Bioguard Corporation Companion Animal Tumor Screening Service Product and Services
9.13.4 Bioguard Corporation Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Bioguard Corporation Recent Developments/Updates
9.13.6 Bioguard Corporation Competitive Strengths & Weaknesses
9.14 CanCan Diagnostics
9.14.1 CanCan Diagnostics Details
9.14.2 CanCan Diagnostics Major Business
9.14.3 CanCan Diagnostics Companion Animal Tumor Screening Service Product and Services
9.14.4 CanCan Diagnostics Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 CanCan Diagnostics Recent Developments/Updates
9.14.6 CanCan Diagnostics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Companion Animal Tumor Screening Service Industry Chain
10.2 Companion Animal Tumor Screening Service Upstream Analysis
10.3 Companion Animal Tumor Screening Service Midstream Analysis
10.4 Companion Animal Tumor Screening Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Companion Animal Tumor Screening Service Introduction
1.2 World Companion Animal Tumor Screening Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Companion Animal Tumor Screening Service Total Market by Region (by Headquarter Location)
1.3.1 World Companion Animal Tumor Screening Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Companion Animal Tumor Screening Service Revenue (2021-2032)
1.3.3 China Based Company Companion Animal Tumor Screening Service Revenue (2021-2032)
1.3.4 Europe Based Company Companion Animal Tumor Screening Service Revenue (2021-2032)
1.3.5 Japan Based Company Companion Animal Tumor Screening Service Revenue (2021-2032)
1.3.6 South Korea Based Company Companion Animal Tumor Screening Service Revenue (2021-2032)
1.3.7 ASEAN Based Company Companion Animal Tumor Screening Service Revenue (2021-2032)
1.3.8 India Based Company Companion Animal Tumor Screening Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Companion Animal Tumor Screening Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Companion Animal Tumor Screening Service Consumption Value (2021-2032)
2.2 World Companion Animal Tumor Screening Service Consumption Value by Region
2.2.1 World Companion Animal Tumor Screening Service Consumption Value by Region (2021-2026)
2.2.2 World Companion Animal Tumor Screening Service Consumption Value Forecast by Region (2027-2032)
2.3 United States Companion Animal Tumor Screening Service Consumption Value (2021-2032)
2.4 China Companion Animal Tumor Screening Service Consumption Value (2021-2032)
2.5 Europe Companion Animal Tumor Screening Service Consumption Value (2021-2032)
2.6 Japan Companion Animal Tumor Screening Service Consumption Value (2021-2032)
2.7 South Korea Companion Animal Tumor Screening Service Consumption Value (2021-2032)
2.8 ASEAN Companion Animal Tumor Screening Service Consumption Value (2021-2032)
2.9 India Companion Animal Tumor Screening Service Consumption Value (2021-2032)
3 WORLD COMPANION ANIMAL TUMOR SCREENING SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Companion Animal Tumor Screening Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Companion Animal Tumor Screening Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Companion Animal Tumor Screening Service in 2025
3.2.3 Global Concentration Ratios (CR8) for Companion Animal Tumor Screening Service in 2025
3.3 Companion Animal Tumor Screening Service Company Evaluation Quadrant
3.4 Companion Animal Tumor Screening Service Market: Overall Company Footprint Analysis
3.4.1 Companion Animal Tumor Screening Service Market: Region Footprint
3.4.2 Companion Animal Tumor Screening Service Market: Company Product Type Footprint
3.4.3 Companion Animal Tumor Screening Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Companion Animal Tumor Screening Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Companion Animal Tumor Screening Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Companion Animal Tumor Screening Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Companion Animal Tumor Screening Service Consumption Value Comparison
4.2.1 United States VS China: Companion Animal Tumor Screening Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Companion Animal Tumor Screening Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Companion Animal Tumor Screening Service Companies and Market Share, 2021-2026
4.3.1 United States Based Companion Animal Tumor Screening Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Companion Animal Tumor Screening Service Revenue, (2021-2026)
4.4 China Based Companies Companion Animal Tumor Screening Service Revenue and Market Share, 2021-2026
4.4.1 China Based Companion Animal Tumor Screening Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Companion Animal Tumor Screening Service Revenue, (2021-2026)
4.5 Rest of World Based Companion Animal Tumor Screening Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Companion Animal Tumor Screening Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Companion Animal Tumor Screening Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Companion Animal Tumor Screening Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Blood-based Screening
5.2.2 Urine-based Screening
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Companion Animal Tumor Screening Service Market Size by Type (2021-2026)
5.3.2 World Companion Animal Tumor Screening Service Market Size by Type (2027-2032)
5.3.3 World Companion Animal Tumor Screening Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CANCER COVERAGE
6.1 World Companion Animal Tumor Screening Service Market Size Overview by Cancer Coverage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Cancer Coverage
6.2.1 Multi-cancer Screening Services
6.2.2 Single-cancer Screening Services
6.2.3 Cancer-group Screening Services
6.3 Market Segment by Cancer Coverage
6.3.1 World Companion Animal Tumor Screening Service Market Size by Cancer Coverage (2021-2026)
6.3.2 World Companion Animal Tumor Screening Service Market Size by Cancer Coverage (2027-2032)
6.3.3 World Companion Animal Tumor Screening Service Market Size Market Share by Cancer Coverage (2027-2032)
7 MARKET ANALYSIS BY ANIMAL TYPE
7.1 World Companion Animal Tumor Screening Service Market Size Overview by Animal Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Animal Type
7.2.1 Canine Cancer Screening Services
7.2.2 Feline Cancer Screening Services
7.2.3 Others
7.3 Market Segment by Animal Type
7.3.1 World Companion Animal Tumor Screening Service Market Size by Animal Type (2021-2026)
7.3.2 World Companion Animal Tumor Screening Service Market Size by Animal Type (2027-2032)
7.3.3 World Companion Animal Tumor Screening Service Market Size Market Share by Animal Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Companion Animal Tumor Screening Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Routine Wellness Screening
8.2.2 Senior and High-Risk Animal Screening
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Companion Animal Tumor Screening Service Market Size by Application (2021-2026)
8.3.2 World Companion Animal Tumor Screening Service Market Size by Application (2027-2032)
8.3.3 World Companion Animal Tumor Screening Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 IDEXX Laboratories
9.1.1 IDEXX Laboratories Details
9.1.2 IDEXX Laboratories Major Business
9.1.3 IDEXX Laboratories Companion Animal Tumor Screening Service Product and Services
9.1.4 IDEXX Laboratories Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 IDEXX Laboratories Recent Developments/Updates
9.1.6 IDEXX Laboratories Competitive Strengths & Weaknesses
9.2 Antech Diagnostics
9.2.1 Antech Diagnostics Details
9.2.2 Antech Diagnostics Major Business
9.2.3 Antech Diagnostics Companion Animal Tumor Screening Service Product and Services
9.2.4 Antech Diagnostics Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Antech Diagnostics Recent Developments/Updates
9.2.6 Antech Diagnostics Competitive Strengths & Weaknesses
9.3 VolitionRx
9.3.1 VolitionRx Details
9.3.2 VolitionRx Major Business
9.3.3 VolitionRx Companion Animal Tumor Screening Service Product and Services
9.3.4 VolitionRx Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 VolitionRx Recent Developments/Updates
9.3.6 VolitionRx Competitive Strengths & Weaknesses
9.4 Fujifilm
9.4.1 Fujifilm Details
9.4.2 Fujifilm Major Business
9.4.3 Fujifilm Companion Animal Tumor Screening Service Product and Services
9.4.4 Fujifilm Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Fujifilm Recent Developments/Updates
9.4.6 Fujifilm Competitive Strengths & Weaknesses
9.5 Zoetis Diagnostics
9.5.1 Zoetis Diagnostics Details
9.5.2 Zoetis Diagnostics Major Business
9.5.3 Zoetis Diagnostics Companion Animal Tumor Screening Service Product and Services
9.5.4 Zoetis Diagnostics Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Zoetis Diagnostics Recent Developments/Updates
9.5.6 Zoetis Diagnostics Competitive Strengths & Weaknesses
9.6 LABOKLIN
9.6.1 LABOKLIN Details
9.6.2 LABOKLIN Major Business
9.6.3 LABOKLIN Companion Animal Tumor Screening Service Product and Services
9.6.4 LABOKLIN Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 LABOKLIN Recent Developments/Updates
9.6.6 LABOKLIN Competitive Strengths & Weaknesses
9.7 NationWide Laboratories
9.7.1 NationWide Laboratories Details
9.7.2 NationWide Laboratories Major Business
9.7.3 NationWide Laboratories Companion Animal Tumor Screening Service Product and Services
9.7.4 NationWide Laboratories Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 NationWide Laboratories Recent Developments/Updates
9.7.6 NationWide Laboratories Competitive Strengths & Weaknesses
9.8 Midwest Vet Labs
9.8.1 Midwest Vet Labs Details
9.8.2 Midwest Vet Labs Major Business
9.8.3 Midwest Vet Labs Companion Animal Tumor Screening Service Product and Services
9.8.4 Midwest Vet Labs Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Midwest Vet Labs Recent Developments/Updates
9.8.6 Midwest Vet Labs Competitive Strengths & Weaknesses
9.9 VDI Laboratory
9.9.1 VDI Laboratory Details
9.9.2 VDI Laboratory Major Business
9.9.3 VDI Laboratory Companion Animal Tumor Screening Service Product and Services
9.9.4 VDI Laboratory Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 VDI Laboratory Recent Developments/Updates
9.9.6 VDI Laboratory Competitive Strengths & Weaknesses
9.10 HT Vet
9.10.1 HT Vet Details
9.10.2 HT Vet Major Business
9.10.3 HT Vet Companion Animal Tumor Screening Service Product and Services
9.10.4 HT Vet Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 HT Vet Recent Developments/Updates
9.10.6 HT Vet Competitive Strengths & Weaknesses
9.11 Oncotect
9.11.1 Oncotect Details
9.11.2 Oncotect Major Business
9.11.3 Oncotect Companion Animal Tumor Screening Service Product and Services
9.11.4 Oncotect Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Oncotect Recent Developments/Updates
9.11.6 Oncotect Competitive Strengths & Weaknesses
9.12 PETcision
9.12.1 PETcision Details
9.12.2 PETcision Major Business
9.12.3 PETcision Companion Animal Tumor Screening Service Product and Services
9.12.4 PETcision Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 PETcision Recent Developments/Updates
9.12.6 PETcision Competitive Strengths & Weaknesses
9.13 Bioguard Corporation
9.13.1 Bioguard Corporation Details
9.13.2 Bioguard Corporation Major Business
9.13.3 Bioguard Corporation Companion Animal Tumor Screening Service Product and Services
9.13.4 Bioguard Corporation Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Bioguard Corporation Recent Developments/Updates
9.13.6 Bioguard Corporation Competitive Strengths & Weaknesses
9.14 CanCan Diagnostics
9.14.1 CanCan Diagnostics Details
9.14.2 CanCan Diagnostics Major Business
9.14.3 CanCan Diagnostics Companion Animal Tumor Screening Service Product and Services
9.14.4 CanCan Diagnostics Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 CanCan Diagnostics Recent Developments/Updates
9.14.6 CanCan Diagnostics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Companion Animal Tumor Screening Service Industry Chain
10.2 Companion Animal Tumor Screening Service Upstream Analysis
10.3 Companion Animal Tumor Screening Service Midstream Analysis
10.4 Companion Animal Tumor Screening Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Companion Animal Tumor Screening Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Companion Animal Tumor Screening Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Companion Animal Tumor Screening Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Companion Animal Tumor Screening Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Companion Animal Tumor Screening Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Companion Animal Tumor Screening Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Companion Animal Tumor Screening Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Companion Animal Tumor Screening Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Companion Animal Tumor Screening Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Companion Animal Tumor Screening Service Players in 2025
Table 12. World Companion Animal Tumor Screening Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Companion Animal Tumor Screening Service Company Evaluation Quadrant
Table 14. Head Office of Key Companion Animal Tumor Screening Service Players
Table 15. Companion Animal Tumor Screening Service Market: Company Product Type Footprint
Table 16. Companion Animal Tumor Screening Service Market: Company Product Application Footprint
Table 17. Companion Animal Tumor Screening Service Mergers & Acquisitions Activity
Table 18. United States VS China Companion Animal Tumor Screening Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Companion Animal Tumor Screening Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Companion Animal Tumor Screening Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Companion Animal Tumor Screening Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Companion Animal Tumor Screening Service Revenue Market Share (2021-2026)
Table 23. China Based Companion Animal Tumor Screening Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Companion Animal Tumor Screening Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Companion Animal Tumor Screening Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based Companion Animal Tumor Screening Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Companion Animal Tumor Screening Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Companion Animal Tumor Screening Service Revenue Market Share (2021-2026)
Table 29. World Companion Animal Tumor Screening Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Companion Animal Tumor Screening Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Companion Animal Tumor Screening Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World Companion Animal Tumor Screening Service Market Size by Cancer Coverage, (USD Million), 2021 & 2025 & 2032
Table 33. World Companion Animal Tumor Screening Service Market Size Value by Cancer Coverage (2021-2026) & (USD Million)
Table 34. World Companion Animal Tumor Screening Service Market Size by Cancer Coverage (2027-2032) & (USD Million)
Table 35. World Companion Animal Tumor Screening Service Market Size by Animal Type, (USD Million), 2021 & 2025 & 2032
Table 36. World Companion Animal Tumor Screening Service Market Size Value by Animal Type (2021-2026) & (USD Million)
Table 37. World Companion Animal Tumor Screening Service Market Size by Animal Type (2027-2032) & (USD Million)
Table 38. World Companion Animal Tumor Screening Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Companion Animal Tumor Screening Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World Companion Animal Tumor Screening Service Market Size by Application (2027-2032) & (USD Million)
Table 41. IDEXX Laboratories Basic Information, Manufacturing Base and Competitors
Table 42. IDEXX Laboratories Major Business
Table 43. IDEXX Laboratories Companion Animal Tumor Screening Service Product and Services
Table 44. IDEXX Laboratories Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. IDEXX Laboratories Recent Developments/Updates
Table 46. IDEXX Laboratories Competitive Strengths & Weaknesses
Table 47. Antech Diagnostics Basic Information, Manufacturing Base and Competitors
Table 48. Antech Diagnostics Major Business
Table 49. Antech Diagnostics Companion Animal Tumor Screening Service Product and Services
Table 50. Antech Diagnostics Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Antech Diagnostics Recent Developments/Updates
Table 52. Antech Diagnostics Competitive Strengths & Weaknesses
Table 53. VolitionRx Basic Information, Manufacturing Base and Competitors
Table 54. VolitionRx Major Business
Table 55. VolitionRx Companion Animal Tumor Screening Service Product and Services
Table 56. VolitionRx Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. VolitionRx Recent Developments/Updates
Table 58. VolitionRx Competitive Strengths & Weaknesses
Table 59. Fujifilm Basic Information, Manufacturing Base and Competitors
Table 60. Fujifilm Major Business
Table 61. Fujifilm Companion Animal Tumor Screening Service Product and Services
Table 62. Fujifilm Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Fujifilm Recent Developments/Updates
Table 64. Fujifilm Competitive Strengths & Weaknesses
Table 65. Zoetis Diagnostics Basic Information, Manufacturing Base and Competitors
Table 66. Zoetis Diagnostics Major Business
Table 67. Zoetis Diagnostics Companion Animal Tumor Screening Service Product and Services
Table 68. Zoetis Diagnostics Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Zoetis Diagnostics Recent Developments/Updates
Table 70. Zoetis Diagnostics Competitive Strengths & Weaknesses
Table 71. LABOKLIN Basic Information, Manufacturing Base and Competitors
Table 72. LABOKLIN Major Business
Table 73. LABOKLIN Companion Animal Tumor Screening Service Product and Services
Table 74. LABOKLIN Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. LABOKLIN Recent Developments/Updates
Table 76. LABOKLIN Competitive Strengths & Weaknesses
Table 77. NationWide Laboratories Basic Information, Manufacturing Base and Competitors
Table 78. NationWide Laboratories Major Business
Table 79. NationWide Laboratories Companion Animal Tumor Screening Service Product and Services
Table 80. NationWide Laboratories Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. NationWide Laboratories Recent Developments/Updates
Table 82. NationWide Laboratories Competitive Strengths & Weaknesses
Table 83. Midwest Vet Labs Basic Information, Manufacturing Base and Competitors
Table 84. Midwest Vet Labs Major Business
Table 85. Midwest Vet Labs Companion Animal Tumor Screening Service Product and Services
Table 86. Midwest Vet Labs Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Midwest Vet Labs Recent Developments/Updates
Table 88. Midwest Vet Labs Competitive Strengths & Weaknesses
Table 89. VDI Laboratory Basic Information, Manufacturing Base and Competitors
Table 90. VDI Laboratory Major Business
Table 91. VDI Laboratory Companion Animal Tumor Screening Service Product and Services
Table 92. VDI Laboratory Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. VDI Laboratory Recent Developments/Updates
Table 94. VDI Laboratory Competitive Strengths & Weaknesses
Table 95. HT Vet Basic Information, Manufacturing Base and Competitors
Table 96. HT Vet Major Business
Table 97. HT Vet Companion Animal Tumor Screening Service Product and Services
Table 98. HT Vet Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. HT Vet Recent Developments/Updates
Table 100. HT Vet Competitive Strengths & Weaknesses
Table 101. Oncotect Basic Information, Manufacturing Base and Competitors
Table 102. Oncotect Major Business
Table 103. Oncotect Companion Animal Tumor Screening Service Product and Services
Table 104. Oncotect Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Oncotect Recent Developments/Updates
Table 106. Oncotect Competitive Strengths & Weaknesses
Table 107. PETcision Basic Information, Manufacturing Base and Competitors
Table 108. PETcision Major Business
Table 109. PETcision Companion Animal Tumor Screening Service Product and Services
Table 110. PETcision Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. PETcision Recent Developments/Updates
Table 112. PETcision Competitive Strengths & Weaknesses
Table 113. Bioguard Corporation Basic Information, Manufacturing Base and Competitors
Table 114. Bioguard Corporation Major Business
Table 115. Bioguard Corporation Companion Animal Tumor Screening Service Product and Services
Table 116. Bioguard Corporation Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Bioguard Corporation Recent Developments/Updates
Table 118. Bioguard Corporation Competitive Strengths & Weaknesses
Table 119. CanCan Diagnostics Basic Information, Manufacturing Base and Competitors
Table 120. CanCan Diagnostics Major Business
Table 121. CanCan Diagnostics Companion Animal Tumor Screening Service Product and Services
Table 122. CanCan Diagnostics Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. CanCan Diagnostics Recent Developments/Updates
Table 124. CanCan Diagnostics Competitive Strengths & Weaknesses
Table 125. Global Key Players of Companion Animal Tumor Screening Service Upstream (Raw Materials)
Table 126. Global Companion Animal Tumor Screening Service Typical Customers
Table 1. World Companion Animal Tumor Screening Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Companion Animal Tumor Screening Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Companion Animal Tumor Screening Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Companion Animal Tumor Screening Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Companion Animal Tumor Screening Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Companion Animal Tumor Screening Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Companion Animal Tumor Screening Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Companion Animal Tumor Screening Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Companion Animal Tumor Screening Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Companion Animal Tumor Screening Service Players in 2025
Table 12. World Companion Animal Tumor Screening Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Companion Animal Tumor Screening Service Company Evaluation Quadrant
Table 14. Head Office of Key Companion Animal Tumor Screening Service Players
Table 15. Companion Animal Tumor Screening Service Market: Company Product Type Footprint
Table 16. Companion Animal Tumor Screening Service Market: Company Product Application Footprint
Table 17. Companion Animal Tumor Screening Service Mergers & Acquisitions Activity
Table 18. United States VS China Companion Animal Tumor Screening Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Companion Animal Tumor Screening Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Companion Animal Tumor Screening Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Companion Animal Tumor Screening Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Companion Animal Tumor Screening Service Revenue Market Share (2021-2026)
Table 23. China Based Companion Animal Tumor Screening Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Companion Animal Tumor Screening Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Companion Animal Tumor Screening Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based Companion Animal Tumor Screening Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Companion Animal Tumor Screening Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Companion Animal Tumor Screening Service Revenue Market Share (2021-2026)
Table 29. World Companion Animal Tumor Screening Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Companion Animal Tumor Screening Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Companion Animal Tumor Screening Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World Companion Animal Tumor Screening Service Market Size by Cancer Coverage, (USD Million), 2021 & 2025 & 2032
Table 33. World Companion Animal Tumor Screening Service Market Size Value by Cancer Coverage (2021-2026) & (USD Million)
Table 34. World Companion Animal Tumor Screening Service Market Size by Cancer Coverage (2027-2032) & (USD Million)
Table 35. World Companion Animal Tumor Screening Service Market Size by Animal Type, (USD Million), 2021 & 2025 & 2032
Table 36. World Companion Animal Tumor Screening Service Market Size Value by Animal Type (2021-2026) & (USD Million)
Table 37. World Companion Animal Tumor Screening Service Market Size by Animal Type (2027-2032) & (USD Million)
Table 38. World Companion Animal Tumor Screening Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Companion Animal Tumor Screening Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World Companion Animal Tumor Screening Service Market Size by Application (2027-2032) & (USD Million)
Table 41. IDEXX Laboratories Basic Information, Manufacturing Base and Competitors
Table 42. IDEXX Laboratories Major Business
Table 43. IDEXX Laboratories Companion Animal Tumor Screening Service Product and Services
Table 44. IDEXX Laboratories Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. IDEXX Laboratories Recent Developments/Updates
Table 46. IDEXX Laboratories Competitive Strengths & Weaknesses
Table 47. Antech Diagnostics Basic Information, Manufacturing Base and Competitors
Table 48. Antech Diagnostics Major Business
Table 49. Antech Diagnostics Companion Animal Tumor Screening Service Product and Services
Table 50. Antech Diagnostics Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Antech Diagnostics Recent Developments/Updates
Table 52. Antech Diagnostics Competitive Strengths & Weaknesses
Table 53. VolitionRx Basic Information, Manufacturing Base and Competitors
Table 54. VolitionRx Major Business
Table 55. VolitionRx Companion Animal Tumor Screening Service Product and Services
Table 56. VolitionRx Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. VolitionRx Recent Developments/Updates
Table 58. VolitionRx Competitive Strengths & Weaknesses
Table 59. Fujifilm Basic Information, Manufacturing Base and Competitors
Table 60. Fujifilm Major Business
Table 61. Fujifilm Companion Animal Tumor Screening Service Product and Services
Table 62. Fujifilm Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Fujifilm Recent Developments/Updates
Table 64. Fujifilm Competitive Strengths & Weaknesses
Table 65. Zoetis Diagnostics Basic Information, Manufacturing Base and Competitors
Table 66. Zoetis Diagnostics Major Business
Table 67. Zoetis Diagnostics Companion Animal Tumor Screening Service Product and Services
Table 68. Zoetis Diagnostics Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Zoetis Diagnostics Recent Developments/Updates
Table 70. Zoetis Diagnostics Competitive Strengths & Weaknesses
Table 71. LABOKLIN Basic Information, Manufacturing Base and Competitors
Table 72. LABOKLIN Major Business
Table 73. LABOKLIN Companion Animal Tumor Screening Service Product and Services
Table 74. LABOKLIN Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. LABOKLIN Recent Developments/Updates
Table 76. LABOKLIN Competitive Strengths & Weaknesses
Table 77. NationWide Laboratories Basic Information, Manufacturing Base and Competitors
Table 78. NationWide Laboratories Major Business
Table 79. NationWide Laboratories Companion Animal Tumor Screening Service Product and Services
Table 80. NationWide Laboratories Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. NationWide Laboratories Recent Developments/Updates
Table 82. NationWide Laboratories Competitive Strengths & Weaknesses
Table 83. Midwest Vet Labs Basic Information, Manufacturing Base and Competitors
Table 84. Midwest Vet Labs Major Business
Table 85. Midwest Vet Labs Companion Animal Tumor Screening Service Product and Services
Table 86. Midwest Vet Labs Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Midwest Vet Labs Recent Developments/Updates
Table 88. Midwest Vet Labs Competitive Strengths & Weaknesses
Table 89. VDI Laboratory Basic Information, Manufacturing Base and Competitors
Table 90. VDI Laboratory Major Business
Table 91. VDI Laboratory Companion Animal Tumor Screening Service Product and Services
Table 92. VDI Laboratory Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. VDI Laboratory Recent Developments/Updates
Table 94. VDI Laboratory Competitive Strengths & Weaknesses
Table 95. HT Vet Basic Information, Manufacturing Base and Competitors
Table 96. HT Vet Major Business
Table 97. HT Vet Companion Animal Tumor Screening Service Product and Services
Table 98. HT Vet Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. HT Vet Recent Developments/Updates
Table 100. HT Vet Competitive Strengths & Weaknesses
Table 101. Oncotect Basic Information, Manufacturing Base and Competitors
Table 102. Oncotect Major Business
Table 103. Oncotect Companion Animal Tumor Screening Service Product and Services
Table 104. Oncotect Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Oncotect Recent Developments/Updates
Table 106. Oncotect Competitive Strengths & Weaknesses
Table 107. PETcision Basic Information, Manufacturing Base and Competitors
Table 108. PETcision Major Business
Table 109. PETcision Companion Animal Tumor Screening Service Product and Services
Table 110. PETcision Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. PETcision Recent Developments/Updates
Table 112. PETcision Competitive Strengths & Weaknesses
Table 113. Bioguard Corporation Basic Information, Manufacturing Base and Competitors
Table 114. Bioguard Corporation Major Business
Table 115. Bioguard Corporation Companion Animal Tumor Screening Service Product and Services
Table 116. Bioguard Corporation Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Bioguard Corporation Recent Developments/Updates
Table 118. Bioguard Corporation Competitive Strengths & Weaknesses
Table 119. CanCan Diagnostics Basic Information, Manufacturing Base and Competitors
Table 120. CanCan Diagnostics Major Business
Table 121. CanCan Diagnostics Companion Animal Tumor Screening Service Product and Services
Table 122. CanCan Diagnostics Companion Animal Tumor Screening Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. CanCan Diagnostics Recent Developments/Updates
Table 124. CanCan Diagnostics Competitive Strengths & Weaknesses
Table 125. Global Key Players of Companion Animal Tumor Screening Service Upstream (Raw Materials)
Table 126. Global Companion Animal Tumor Screening Service Typical Customers
LIST OF FIGURES
Figure 1. Companion Animal Tumor Screening Service Picture
Figure 2. World Companion Animal Tumor Screening Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Companion Animal Tumor Screening Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World Companion Animal Tumor Screening Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Companion Animal Tumor Screening Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Companion Animal Tumor Screening Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Companion Animal Tumor Screening Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Companion Animal Tumor Screening Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Companion Animal Tumor Screening Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Companion Animal Tumor Screening Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Companion Animal Tumor Screening Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Companion Animal Tumor Screening Service Revenue (2021-2032) & (USD Million)
Figure 13. Companion Animal Tumor Screening Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Companion Animal Tumor Screening Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World Companion Animal Tumor Screening Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Companion Animal Tumor Screening Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China Companion Animal Tumor Screening Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Companion Animal Tumor Screening Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Companion Animal Tumor Screening Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Companion Animal Tumor Screening Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Companion Animal Tumor Screening Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India Companion Animal Tumor Screening Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Companion Animal Tumor Screening Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Companion Animal Tumor Screening Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Companion Animal Tumor Screening Service Markets in 2025
Figure 27. United States VS China: Companion Animal Tumor Screening Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Companion Animal Tumor Screening Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Companion Animal Tumor Screening Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Companion Animal Tumor Screening Service Market Size Market Share by Type in 2025
Figure 31. Blood-based Screening
Figure 32. Urine-based Screening
Figure 33. Others
Figure 34. World Companion Animal Tumor Screening Service Market Size Market Share by Type (2021-2032)
Figure 35. World Companion Animal Tumor Screening Service Market Size by Cancer Coverage, (USD Million), 2021 & 2025 & 2032
Figure 36. World Companion Animal Tumor Screening Service Market Size Market Share by Cancer Coverage in 2025
Figure 37. Multi-cancer Screening Services
Figure 38. Single-cancer Screening Services
Figure 39. Cancer-group Screening Services
Figure 40. World Companion Animal Tumor Screening Service Market Size Market Share by Cancer Coverage (2021-2032)
Figure 41. World Companion Animal Tumor Screening Service Market Size by Animal Type, (USD Million), 2021 & 2025 & 2032
Figure 42. World Companion Animal Tumor Screening Service Market Size Market Share by Animal Type in 2025
Figure 43. Canine Cancer Screening Services
Figure 44. Feline Cancer Screening Services
Figure 45. Others
Figure 46. World Companion Animal Tumor Screening Service Market Size Market Share by Animal Type (2021-2032)
Figure 47. World Companion Animal Tumor Screening Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Companion Animal Tumor Screening Service Market Size Market Share by Application in 2025
Figure 49. Routine Wellness Screening
Figure 50. Senior and High-Risk Animal Screening
Figure 51. Others
Figure 52. World Companion Animal Tumor Screening Service Market Size Market Share by Application (2021-2032)
Figure 53. Companion Animal Tumor Screening Service Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Companion Animal Tumor Screening Service Picture
Figure 2. World Companion Animal Tumor Screening Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Companion Animal Tumor Screening Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World Companion Animal Tumor Screening Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Companion Animal Tumor Screening Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Companion Animal Tumor Screening Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Companion Animal Tumor Screening Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Companion Animal Tumor Screening Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Companion Animal Tumor Screening Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Companion Animal Tumor Screening Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Companion Animal Tumor Screening Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Companion Animal Tumor Screening Service Revenue (2021-2032) & (USD Million)
Figure 13. Companion Animal Tumor Screening Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Companion Animal Tumor Screening Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World Companion Animal Tumor Screening Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Companion Animal Tumor Screening Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China Companion Animal Tumor Screening Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Companion Animal Tumor Screening Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Companion Animal Tumor Screening Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Companion Animal Tumor Screening Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Companion Animal Tumor Screening Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India Companion Animal Tumor Screening Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Companion Animal Tumor Screening Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Companion Animal Tumor Screening Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Companion Animal Tumor Screening Service Markets in 2025
Figure 27. United States VS China: Companion Animal Tumor Screening Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Companion Animal Tumor Screening Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Companion Animal Tumor Screening Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Companion Animal Tumor Screening Service Market Size Market Share by Type in 2025
Figure 31. Blood-based Screening
Figure 32. Urine-based Screening
Figure 33. Others
Figure 34. World Companion Animal Tumor Screening Service Market Size Market Share by Type (2021-2032)
Figure 35. World Companion Animal Tumor Screening Service Market Size by Cancer Coverage, (USD Million), 2021 & 2025 & 2032
Figure 36. World Companion Animal Tumor Screening Service Market Size Market Share by Cancer Coverage in 2025
Figure 37. Multi-cancer Screening Services
Figure 38. Single-cancer Screening Services
Figure 39. Cancer-group Screening Services
Figure 40. World Companion Animal Tumor Screening Service Market Size Market Share by Cancer Coverage (2021-2032)
Figure 41. World Companion Animal Tumor Screening Service Market Size by Animal Type, (USD Million), 2021 & 2025 & 2032
Figure 42. World Companion Animal Tumor Screening Service Market Size Market Share by Animal Type in 2025
Figure 43. Canine Cancer Screening Services
Figure 44. Feline Cancer Screening Services
Figure 45. Others
Figure 46. World Companion Animal Tumor Screening Service Market Size Market Share by Animal Type (2021-2032)
Figure 47. World Companion Animal Tumor Screening Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Companion Animal Tumor Screening Service Market Size Market Share by Application in 2025
Figure 49. Routine Wellness Screening
Figure 50. Senior and High-Risk Animal Screening
Figure 51. Others
Figure 52. World Companion Animal Tumor Screening Service Market Size Market Share by Application (2021-2032)
Figure 53. Companion Animal Tumor Screening Service Industrial Chain
Figure 54. Methodology
Figure 55. Research Process and Data Source
